Anti-CTLA-4 antibody and CpG-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
A Standard patent application filed on 30 June 2006 credited to Krieg, Arthur M. ; Readett, David Robert John ; Gomez-Novarro, Jesus ; Jungnelius, Jarl Ulf Birger ; Hanson, Douglas C.

Details

Application number :

2006269555  

Application type :

Standard  

Application status :

FILED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Anti-CTLA-4 antibody and CpG-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment  

Inventor :

Krieg, Arthur M. ; Readett, David Robert John ; Gomez-Novarro, Jesus ; Jungnelius, Jarl Ulf Birger ; Hanson, Douglas C.  

Agent name :

Shelston IP  

Address for service :

Level 21 60 Margaret Street Sydney NSW 2000 Australia  

Filing date :

30 June 2006  

Associated companies :

 

Applicant name :

Pfizer Inc.  

Applicant address :

235 East 42nd Street New York NY 10017 United States of America  

Old name :

 

Original Source :

Go